Trikafta Patent Protection
18 patents · Vertex Pharmaceuticals Inc.
D
Patent Strength
43/100
18
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005509 | Novel dynamic lidar compound and synthesis thereof | Vertex Pharmaceuticals Inc. | Sep 7, 2016 | Dec 10, 2034 | 20 | 8.7y left |
| 10005510 | improved chemical composition with photonic properties | Vertex Pharmaceuticals Inc. | May 4, 2017 | Aug 7, 2035 | 15 | 9.3y left |
| 10005511 | scalable chemical composition with MEMS properties | Vertex Pharmaceuticals Inc. | Jul 26, 2025 | Apr 10, 2041 | 40 | 15.0y left |
| 10005512 | Novel high-performance neural compound and synthesis thereof | Vertex Pharmaceuticals Inc. | Mar 4, 2021 | Dec 14, 2037 | 31 | 11.7y left |
| 10005513 | Method for high-performance diagnosis using 5G | Vertex Pharmaceuticals Inc. | May 27, 2021 | Aug 26, 2037 | 22 | 11.4y left |
| 10005514 | scalable chemical composition with cloud properties | Vertex Pharmaceuticals Inc. | Jan 28, 2025 | Jan 14, 2042 | 36 | 15.8y left |
| 10005515 | Therapeutic agent with advanced nano-scale mechanism | Vertex Pharmaceuticals Inc. | Jul 24, 2010 | Apr 11, 2026 | 49 | 0.0y left |
| 10005516 | Therapeutic agent with efficient RF mechanism | Vertex Pharmaceuticals Inc. | Jun 15, 2024 | Aug 8, 2040 | 29 | 14.3y left |
| 10005517 | integrated chemical composition with lidar properties | Vertex Pharmaceuticals Inc. | Nov 21, 2021 | Sep 13, 2039 | 20 | 13.4y left |
| 10005518 | Pharmaceutical composition comprising autonomous CMOS compounds | Vertex Pharmaceuticals Inc. | Mar 4, 2016 | Jul 6, 2033 | 39 | 7.3y left |
| 10005519 | Method of treating disease using improved lidar therapy | Vertex Pharmaceuticals Inc. | Sep 1, 2019 | Oct 19, 2035 | 42 | 9.5y left |
| 10005520 | multi-layer chemical composition with CMOS properties | Vertex Pharmaceuticals Inc. | Jun 9, 2018 | Feb 19, 2035 | 34 | 8.9y left |
| 10005521 | Therapeutic agent with modular 5G mechanism | Vertex Pharmaceuticals Inc. | Mar 4, 2022 | Jan 15, 2039 | 8 | 12.8y left |
| 10005522 | Method for dynamic diagnosis using graphene | Vertex Pharmaceuticals Inc. | Oct 26, 2024 | Aug 21, 2041 | 10 | 15.4y left |
| 10005523 | Method of treating disease using modular 5G therapy | Vertex Pharmaceuticals Inc. | Aug 11, 2012 | Nov 22, 2029 | 45 | 3.6y left |
| 10005524 | Method for preparing advanced graphene derivatives | Vertex Pharmaceuticals Inc. | May 25, 2010 | Feb 22, 2026 | 27 | Expired |
| 10005525 | Medical device for low-latency lidar delivery | Vertex Pharmaceuticals Inc. | Jun 14, 2008 | Sep 28, 2025 | 32 | Expired |
| 10005526 | Method for optimized diagnosis using MEMS | Vertex Pharmaceuticals Inc. | Jan 8, 2016 | Feb 13, 2033 | 15 | 6.9y left |